Kennedy eyes fast-tracking approval for rare disease drugs By Sneha S K and Sriparna Roy Reuters Jun 5, 2025 Health and Human Services Secretary Robert F. Kennedy Jr. said on Thursday that the U.S. drugs regulator would look for ways to fast-track app…
FDA approves Novavax COVID vaccine with new conditions By Reuters May 17, 2025 U.S. Food and Drug Administration ohas approved Novavax's COVID-19 vaccine, but placed additional conditions on individuals who would be able …
UnitedHealth CEO leaves abruptly By Reuters May 13, 2025 UnitedHealth Group said iCEO Andrew Witty resigned Tuesday, and the company suspended its annual forecast due to surging medical costs, sendin…
FDA names agency critic Prasad as top vaccine official By Dan Levine and Julie Steenhuysen Reuters May 6, 2025 U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has criticized FDA leadership and COVID-19 mandates, as director o…
US accuses health insurers, brokers of Medicare Advantage kickback scheme May 1, 2025 By Nate Raymond
UnitedHealth spent $1.7M on executive security in 2024, filing shows By Reuters Apr 21, 2025 UnitedHealth Group spent nearly $1.7 million on security for its top executives in 2024, the healthcare conglomerate disclosed on Monday, mont…
Walgreens to pay $300 million in opioid settlement Reuters Apr 21, 2025 Walgreens has agreed to pay $300 million to settle prosecutors' allegations that it illegally filled millions of invalid prescriptions for opi…
Kudos to EPA, FDA for phase-out of animal testing By聽Niki Davis Utah News Dispatch Apr 19, 2025 As a board-certified family and lifestyle medicine physician in Salt Lake City, I laud both聽 Food and Drug Administration and Environmental Pr…
States try to curtail health insurers鈥� claim denials, with mixed results By Shalina Chatlani Stateline Mar 25, 2025 Health insurance companies are under increasing scrutiny for allegedly using聽artificial intelligence bots聽and algorithms to swiftly deny patie…
Drugmakers agree to participate in second round of price negotiation By Reuters Mar 14, 2025 All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second round of price talks have agre…
